More on SPRB

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (7.7 Score)

Upcoming Events

- Earnings (3/31/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Spruce Biosciences (NQ:SPRB)
Delayed: 43.45 +0.37 (0.86%)
Prev. Close $43.08  
Open$42.64 
52 Wk High$ 
52 Wk Low$ 
Day High$45.51 
Day Low$42.64 
P/E N/A  
EPS$ 
Volume30,313 

Friends, Peers and Foes (?): SPRBD, 6XY SPRUCEBIO (more...)

Jul 27, 2026 08:05 AM Form 8-K SPRUCE BIOSCIENCES, INC. For: Jul 27
Jul 27, 2026 08:00 AM Spruce Biosciences names Adrian Quartel as chief medical officer
Jul 27, 2026 08:00 AM Spruce Biosciences Appoints Adrian Quartel, M.D., FFPM, as Chief Medical Officer
Jul 13, 2026 02:37 AM B.Riley Starts Spruce Biosciences, Inc. (SPRB) at Buy
Jul 9, 2026 04:15 PM Form 4 SPRUCE BIOSCIENCES, INC. For: Jun 30 Filed by: Szwarcberg Javier B.
Jul 8, 2026 04:01 PM Spruce Biosciences to Participate in the B. Riley Securities 2026 Mind, Muscle & Vision Healthcare Summit
Jun 29, 2026 08:01 AM Spruce Biosciences added to Russell 3000 Index
Jun 29, 2026 08:00 AM Spruce Biosciences Joins the Russell 3000® Index
Jun 22, 2026 08:00 AM Spruce Biosciences names medical affairs VP ahead of drug review
Jun 22, 2026 08:00 AM Spruce Biosciences Appoints Agnieszka Jurecka, M.D., Ph.D., MPH, as Vice President, Medical Affairs
View All Articles

Entities mentioned with SPRB

View All Entities